• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过分子对接、分子动力学模拟和 MM/PBSA 方法鉴定 SARS-CoV-2 的 Mpro 天然抑制剂。

Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods.

机构信息

Department of Botany, D.S.B Campus, Kumaun University, Nainital, Uttarakhand, India.

Department of Biotechnology, Bhimtal Campus, Kumaun University Uttarakhand, Bhimtal, Uttarakhand, India.

出版信息

J Biomol Struct Dyn. 2022 Apr;40(6):2757-2768. doi: 10.1080/07391102.2020.1842806. Epub 2020 Nov 4.

DOI:10.1080/07391102.2020.1842806
PMID:33143552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7651194/
Abstract

The recent outbreak of SARS-CoV-2 disease, also known as COVID-19, has emerged as a pandemic. The unavailability of specific therapeutic drugs and vaccines urgently demands sincere efforts for drug discovery against COVID-19. The main protease (Mpro) of SARS-CoV-2 is a critical drug target as it plays an essential role in virus replication. Therefore for the identification of potential inhibitors of SARS-CoV-2 Mpro, we applied a structure-based virtual screening approach followed by molecular dynamics (MD) study. A library of 686 phytochemicals was subjected to virtual screening which resulted in 28 phytochemicals based on binding energy. These phytochemicals were further subjected to drug-likeness and toxicity analysis, which resulted in seven drug-like hits. Out of seven, five phytochemicals viz., Mpro-Dehydrtectol (-10.3 kcal/mol), Epsilon-viniferin (-8.6 kcal/mol), Peimisine (-8.6 kcal/mol), Gmelanone (-8.4 kcal/mol), and Isocolumbin (-8.4 kcal/mol) were non-toxic. Consequently, these phytochemicals are subjected to MD, post MD analysis, and MM/PBSA calculations. The results of 100 ns MD simulation, RMSF, SASA, Rg, and MM/PBSA show that Epsilon-viniferin (-29.240 kJ/mol), Mpro-Peimisine (-43.031 kJ/mol) and Gmelanone (-13.093 kJ/mol) form a stable complex with Mpro and could be used as potential inhibitors of SARS-CoV-2 Mpro. However, further investigation of these inhibitors against Mpro receptor of COVID-19 is needed to validate their candidacy for clinical trials. Communicated by Ramaswamy H. Sarma.

摘要

最近爆发的严重急性呼吸系统综合征冠状病毒 2 型疾病(SARS-CoV-2),又称 COVID-19,已成为一种大流行疾病。由于缺乏特定的治疗药物和疫苗,迫切需要真诚努力寻找针对 COVID-19 的药物。SARS-CoV-2 的主要蛋白酶(Mpro)是一个关键的药物靶点,因为它在病毒复制中起着至关重要的作用。因此,为了鉴定 SARS-CoV-2 Mpro 的潜在抑制剂,我们应用了基于结构的虚拟筛选方法,并结合分子动力学(MD)研究。对 686 种植物化学物质库进行了虚拟筛选,根据结合能得到了 28 种植物化学物质。这些植物化学物质进一步进行了药物相似性和毒性分析,得到了 7 种类药性命中。在这 7 种中,有 5 种植物化学物质,即 Mpro-Dehydrtectol(-10.3 kcal/mol)、Epsilon-viniferin(-8.6 kcal/mol)、Peimisine(-8.6 kcal/mol)、Gmelanone(-8.4 kcal/mol)和 Isocolumbin(-8.4 kcal/mol)是非毒性的。因此,这些植物化学物质被进一步进行 MD、MD 后分析和 MM/PBSA 计算。100 ns MD 模拟的结果、RMSF、SASA、Rg 和 MM/PBSA 表明,Epsilon-viniferin(-29.240 kcal/mol)、Mpro-Peimisine(-43.031 kcal/mol)和 Gmelanone(-13.093 kcal/mol)与 Mpro 形成稳定的复合物,可能作为 SARS-CoV-2 Mpro 的潜在抑制剂。然而,需要进一步研究这些抑制剂对 COVID-19 Mpro 受体的作用,以验证它们作为临床试验候选药物的资格。由 Ramaswamy H. Sarma 通讯。

相似文献

1
Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods.通过分子对接、分子动力学模拟和 MM/PBSA 方法鉴定 SARS-CoV-2 的 Mpro 天然抑制剂。
J Biomol Struct Dyn. 2022 Apr;40(6):2757-2768. doi: 10.1080/07391102.2020.1842806. Epub 2020 Nov 4.
2
Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.从印度香料中鉴定新型抗 nCoV 药物化合物,利用 SARS-CoV-2 主要蛋白酶作为靶点。
J Biomol Struct Dyn. 2021 Jun;39(9):3428-3434. doi: 10.1080/07391102.2020.1763202. Epub 2020 May 13.
3
Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease.基于异吲哚酮的新型SARS-CoV-2主要蛋白酶抑制剂的虚拟高通量筛选、分子对接、密度泛函理论、量子力学/分子力学、分子动力学和分子力学/泊松-玻尔兹曼表面积研究
J Biomol Struct Dyn. 2022 Oct;40(17):7852-7867. doi: 10.1080/07391102.2021.1904003. Epub 2021 Mar 25.
4
Biflavonoids from as probable natural inhibitors against SARS-CoV-2: a molecular docking and molecular dynamics approach.从 中提取的双黄酮类化合物可能是对抗 SARS-CoV-2 的天然抑制剂:一种分子对接和分子动力学方法。
J Biomol Struct Dyn. 2022 Jul;40(10):4376-4388. doi: 10.1080/07391102.2020.1858165. Epub 2020 Dec 10.
5
Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors.靶向 SARS-CoV-2 主蛋白酶:基于结构的虚拟筛选、计算机 ADMET 研究和分子动力学模拟,以鉴定潜在的抑制剂。
J Biomol Struct Dyn. 2022 May;40(8):3609-3625. doi: 10.1080/07391102.2020.1848636. Epub 2020 Nov 23.
6
Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - (Ashwagandha), (Giloy) and (Tulsi) - a molecular docking study.通过阿育吠陀药用植物( Ashwagandha )、( Giloy )和( Tulsi )的活性植物化学成分靶向 COVID-19 ( SARS-CoV-2 )主蛋白酶 - ( Ashwagandha )、( Giloy )和( Tulsi ) - 分子对接研究。
J Biomol Struct Dyn. 2022 Jan;40(1):190-203. doi: 10.1080/07391102.2020.1810778. Epub 2020 Aug 27.
7
Some Flavolignans as Potent Sars-Cov-2 Inhibitors Molecular Docking, Molecular Dynamic Simulations and ADME Analysis.一些类黄酮作为有效的 SARS-CoV-2 抑制剂:分子对接、分子动力学模拟和 ADME 分析。
Curr Comput Aided Drug Des. 2022;18(5):337-346. doi: 10.2174/1573409918666220816113516.
8
Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2.重新利用药物和鉴定 SARS-CoV-2 的整合蛋白(刺突蛋白和主蛋白酶)抑制剂。
J Biomol Struct Dyn. 2022 Sep;40(14):6587-6602. doi: 10.1080/07391102.2021.1886993. Epub 2021 Feb 16.
9
Integrated bioinformatics-cheminformatics approach toward locating pseudo-potential antiviral marine alkaloids against SARS-CoV-2-Mpro.综合生物信息学-化学信息学方法定位抗 SARS-CoV-2-Mpro 的潜在海洋生物碱
Proteins. 2022 Sep;90(9):1617-1633. doi: 10.1002/prot.26341. Epub 2022 Apr 13.
10
Evaluation of phytoconstituents of against K417N and N501Y mutant spike glycoprotein and main protease of SARS-CoV-2- an in silico study.抗 SARS-CoV-2 的 K417N 和 N501Y 突变刺突糖蛋白和主要蛋白酶的植物成分评价 - 一项计算机研究。
J Biomol Struct Dyn. 2023 Jun;41(9):4106-4123. doi: 10.1080/07391102.2022.2062787. Epub 2022 Apr 25.

引用本文的文献

1
Unlocking the potential of phytochemicals in inhibiting SARS-CoV-2 M protein - an in silico and cell-based approach.揭示植物化学物质抑制新型冠状病毒M蛋白的潜力——基于计算机模拟和细胞的方法
Sci Rep. 2025 Jul 2;15(1):22840. doi: 10.1038/s41598-025-05907-z.
2
Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation.金花清感颗粒超高效液相色谱-四级杆-静电场轨道阱高分辨质谱分析:45种潜在抗新冠病毒成分的推定鉴定、补充机密信息及药典质量标志物推荐
J Food Drug Anal. 2023 Aug 31;31(3):534-551. doi: 10.38212/2224-6614.3466.
3
Exploring the Therapeutic Potential of L. Phytochemicals: A Computational Study on Inhibiting SARS-CoV-2's Main Protease (Mpro).探讨 L. 植物化学物质的治疗潜力:抑制 SARS-CoV-2 主要蛋白酶(Mpro)的计算研究。
Molecules. 2024 May 27;29(11):2524. doi: 10.3390/molecules29112524.
4
Harnessing Brazilian biodiversity database: identification of flavonoids as potential inhibitors of SARS-CoV-2 main protease using computational approaches and all-atom molecular dynamics simulation.利用巴西生物多样性数据库:通过计算方法和全原子分子动力学模拟确定黄酮类化合物作为新型冠状病毒主要蛋白酶的潜在抑制剂。
Front Chem. 2024 Feb 22;12:1336001. doi: 10.3389/fchem.2024.1336001. eCollection 2024.
5
Chemical, biological and assessment of date ( L.) fruits grown in Ha'il region.哈伊勒地区种植的椰枣(L.)果实的化学、生物学及评估
Front Chem. 2023 Mar 3;11:1138057. doi: 10.3389/fchem.2023.1138057. eCollection 2023.
6
Repositioning of anti-dengue compounds against SARS-CoV-2 as viral polyprotein processing inhibitor.抗登革病毒化合物对 SARS-CoV-2 的重新定位作为病毒多蛋白加工抑制剂。
PLoS One. 2022 Nov 16;17(11):e0277328. doi: 10.1371/journal.pone.0277328. eCollection 2022.
7
Identification of Drug Combination Therapies for SARS-CoV-2: A Molecular Dynamics Simulations Approach.基于分子动力学模拟的 SARS-CoV-2 药物联合疗法的鉴定。
Drug Des Devel Ther. 2022 Sep 9;16:2995-3013. doi: 10.2147/DDDT.S366423. eCollection 2022.
8
Discovery of a Potent Candidate for RET-Specific Non-Small-Cell Lung Cancer-A Combined In Silico and In Vitro Strategy.通过计算机模拟和体外实验相结合的策略发现一种有效的RET特异性非小细胞肺癌候选药物
Pharmaceutics. 2021 Oct 24;13(11):1775. doi: 10.3390/pharmaceutics13111775.
9
Molecular scaffolds from mother nature as possible lead compounds in drug design and discovery against coronaviruses: A landscape analysis of published literature and molecular docking studies.从大自然母亲中寻找分子支架作为冠状病毒药物设计和发现的潜在先导化合物:已发表文献和分子对接研究的分析。
Microb Pathog. 2021 Aug;157:104933. doi: 10.1016/j.micpath.2021.104933. Epub 2021 May 11.
10
Binding ability of arginine, citrulline, -acetyl citrulline and thiocitrulline with SARS COV-2 main protease using molecular docking studies.利用分子对接研究精氨酸、瓜氨酸、α-乙酰瓜氨酸和硫代瓜氨酸与新型冠状病毒2型主要蛋白酶的结合能力。
Netw Model Anal Health Inform Bioinform. 2021;10(1):28. doi: 10.1007/s13721-021-00301-x. Epub 2021 Apr 6.

本文引用的文献

1
Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method.基于分子对接方法探索传统蒙药活性成分对新型冠状病毒(COVID-19)的干预作用
J Funct Foods. 2020 Aug;71:104016. doi: 10.1016/j.jff.2020.104016. Epub 2020 May 15.
2
Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations.摩洛哥药用植物作为 SARS-CoV-2 主蛋白酶抑制剂的计算研究。
J Biomol Struct Dyn. 2021 May;39(8):2971-2979. doi: 10.1080/07391102.2020.1758790. Epub 2020 May 6.
3
Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment.新型 2019 年冠状病毒结构、作用机制、抗病毒药物前景及其治疗排除。
J Biomol Struct Dyn. 2021 Jun;39(9):3409-3418. doi: 10.1080/07391102.2020.1758788. Epub 2020 Apr 30.
4
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.SARS-CoV-2 在不同类型临床标本中的检测。
JAMA. 2020 May 12;323(18):1843-1844. doi: 10.1001/jama.2020.3786.
5
Genomic variance of the 2019-nCoV coronavirus.2019-nCoV 冠状病毒的基因组变异。
J Med Virol. 2020 May;92(5):522-528. doi: 10.1002/jmv.25700. Epub 2020 Feb 19.
6
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.鉴定一种导致人类严重肺炎的新型冠状病毒:一项描述性研究。
Chin Med J (Engl). 2020 May 5;133(9):1015-1024. doi: 10.1097/CM9.0000000000000722.
7
The 2019-new coronavirus epidemic: Evidence for virus evolution.2019 新型冠状病毒疫情:病毒进化的证据。
J Med Virol. 2020 Apr;92(4):455-459. doi: 10.1002/jmv.25688. Epub 2020 Feb 7.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China.新型冠状病毒持续的2019 - nCoV疫情对全球健康构成威胁——中国武汉最新的2019新型冠状病毒爆发。
Int J Infect Dis. 2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009. Epub 2020 Jan 14.
10
Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.针对阿尔茨海默病的环依赖性激酶 5 进行小分子天然产物的虚拟筛选、药代动力学、分子动力学和结合自由能分析。
J Biomol Struct Dyn. 2020 Jan;38(1):248-262. doi: 10.1080/07391102.2019.1571947. Epub 2019 Feb 21.